- Home
- ABEO vs FRGE Comparison
ABEO vs FRGE Comparison
Compare ABEO & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- FRGE
- Stock Information
- Founded
- ABEO N/A
- FRGE 2014
- Country
- ABEO United States
- FRGE United States
- Employees
- ABEO N/A
- FRGE N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- FRGE Computer Software: Prepackaged Software
- Sector
- ABEO Health Care
- FRGE Technology
- Exchange
- ABEO Nasdaq
- FRGE Nasdaq
- Market Cap
- ABEO 243.9M
- FRGE 256.4M
- IPO Year
- ABEO 1980
- FRGE N/A
- Fundamental
- Price
- ABEO $6.47
- FRGE $1.21
- Analyst Decision
- ABEO Strong Buy
- FRGE Strong Buy
- Analyst Count
- ABEO 3
- FRGE 3
- Target Price
- ABEO $18.00
- FRGE $4.50
- AVG Volume (30 Days)
- ABEO 245.9K
- FRGE 279.8K
- Earning Date
- ABEO 11-11-2024
- FRGE 11-05-2024
- Dividend Yield
- ABEO N/A
- FRGE N/A
- EPS Growth
- ABEO N/A
- FRGE N/A
- EPS
- ABEO N/A
- FRGE N/A
- Revenue
- ABEO N/A
- FRGE $79,146,000.00
- Revenue This Year
- ABEO N/A
- FRGE $29.88
- Revenue Next Year
- ABEO $7,097.06
- FRGE $40.03
- P/E Ratio
- ABEO N/A
- FRGE N/A
- Revenue Growth
- ABEO 147.52
- FRGE 21.91
- 52 Week Low
- ABEO $3.05
- FRGE $1.16
- 52 Week High
- ABEO $9.01
- FRGE $4.02
- Technical
- Relative Strength Index (RSI)
- ABEO 67.41
- FRGE 39.54
- Support Level
- ABEO $6.06
- FRGE $1.28
- Resistance Level
- ABEO $6.48
- FRGE $1.37
- Average True Range (ATR)
- ABEO 0.32
- FRGE 0.07
- MACD
- ABEO 0.05
- FRGE -0.01
- Stochastic Oscillator
- ABEO 99.12
- FRGE 20.50
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.